153 related articles for article (PubMed ID: 17266055)
1. Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome.
Kim YJ; Dale JK; Noel P; Brown MR; Nutman TB; Straus SE; Klion AD
Am J Hematol; 2007 Jul; 82(7):615-24. PubMed ID: 17266055
[TBL] [Abstract][Full Text] [Related]
2. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
[TBL] [Abstract][Full Text] [Related]
3. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
[TBL] [Abstract][Full Text] [Related]
4. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
Narra MB; Abdou NI
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
[TBL] [Abstract][Full Text] [Related]
6. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
[TBL] [Abstract][Full Text] [Related]
8. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
9. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
Hundt M; Posovszky C; Schmidt RE
Immunobiology; 2002 Dec; 206(5):514-8. PubMed ID: 12607726
[TBL] [Abstract][Full Text] [Related]
10. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Maric I; Pittaluga S; Dale JK; Niemela JE; Delsol G; Diment J; Rosai J; Raffeld M; Puck JM; Straus SE; Jaffe ES
Am J Surg Pathol; 2005 Jul; 29(7):903-11. PubMed ID: 15958855
[TBL] [Abstract][Full Text] [Related]
11. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
Straus SE; Sneller M; Lenardo MJ; Puck JM; Strober W
Ann Intern Med; 1999 Apr; 130(7):591-601. PubMed ID: 10189330
[TBL] [Abstract][Full Text] [Related]
12. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
14. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
15. RBC autoantibodies in autoimmune lymphoproliferative syndrome.
Stroncek DF; Carter LB; Procter JL; Dale JK; Straus SE
Transfusion; 2001 Jan; 41(1):18-23. PubMed ID: 11161240
[TBL] [Abstract][Full Text] [Related]
16. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Novicio C; Guarraia D; Dale JK; Straus SE; Fleisher TA
Clin Immunol; 2002 Jul; 104(1):21-30. PubMed ID: 12139944
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy.
Nanan R; Ströbel P; Haas JP; Marx A; Kreth HW
Ann Hematol; 2002 Jun; 81(6):332-5. PubMed ID: 12107564
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
19. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
20. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
